- Home
- Publications
- Publication Search
- Publication Details
Title
The Deadly Duo of COVID-19 and Cancer!
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-12
DOI
10.3389/fmolb.2021.643004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Risk of COVID-19 for cancer patients
- (2020) Yang Xia et al. LANCET ONCOLOGY
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
- (2020) M. Montopoli et al. ANNALS OF ONCOLOGY
- Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
- (2020) Amit Sud et al. ANNALS OF ONCOLOGY
- The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
- (2020) Steven P. Treon et al. BLOOD
- COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature
- (2020) Giuseppe Di Lorenzo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)
- (2020) Elisa Maria Stroppa et al. Future Oncology
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
- (2020) Janice Wang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
- (2020) Andrew I Ritchie et al. LANCET
- Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
- (2020) Avinash G Dinmohamed et al. LANCET ONCOLOGY
- COVID-19 in persons with haematological cancers
- (2020) Wenjuan He et al. LEUKEMIA
- A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 ( COVID ‐19) Pandemic: An International Collaborative Group
- (2020) Humaid O. Al‐Shamsi et al. ONCOLOGIST
- Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system
- (2020) Shuofeng Yuan et al. PHARMACOLOGICAL RESEARCH
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak
- (2020) Mengyuan Dai et al. Cancer Discovery
- COVID-19 in Children With Cancer in New York City
- (2020) Farid Boulad et al. JAMA Oncology
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
- (2020) Jing Yu et al. JAMA Oncology
- Molecular immune pathogenesis and diagnosis of COVID-19
- (2020) Xiaowei Li et al. Journal of Pharmaceutical Analysis
- COVID-19 and cancer research
- (2020) Adrian L. Harris BRITISH JOURNAL OF CANCER
- Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
- (2020) Kamal S. Saini et al. BRITISH JOURNAL OF CANCER
- The Impact of COVID-19 on Cancer Risk and Treatment
- (2020) Nidhi Jyotsana et al. Cellular and Molecular Bioengineering
- SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome
- (2020) Anna M. Di Giacomo et al. EUROPEAN JOURNAL OF CANCER
- Cancer associates with risk and severe events of COVID ‐19: A systematic review and meta‐analysis
- (2020) Yehong Tian et al. INTERNATIONAL JOURNAL OF CANCER
- Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis
- (2020) Yue Zhou et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- (2020) Marina Chiara Garassino et al. LANCET ONCOLOGY
- Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges
- (2020) Alessandro Allegra et al. Cancers
- Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform
- (2020) Marc Peeters et al. ESMO Open
- SARS-CoV-2 and cancer: Are they really partners in crime?
- (2020) Peter A. van Dam et al. CANCER TREATMENT REVIEWS
- Repurposing anticancer drugs for the management of COVID-19
- (2020) Khalid El Bairi et al. EUROPEAN JOURNAL OF CANCER
- Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?
- (2020) Jianping Bi et al. EUROPEAN RESPIRATORY JOURNAL
- Towards modern anticancer agents that interact with tubulin
- (2019) Giuseppe La Regina et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Neutrophil Extracellular Traps
- (2019) Charlotte Thålin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inhibiting Bruton’s tyrosine kinase rescues mice from lethal influenza-induced acute lung injury
- (2018) Jon M. Florence et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Successful use of the potent enzyme inducer enzalutamide in a treatment-experienced HIV-positive male with prostate cancer
- (2018) Salin Nhean et al. AIDS
- High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy
- (2016) Suresh Gopi Kalathil et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells
- (2015) JIN YING et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Challenges in managing hepatitis C virus infection in cancer patients
- (2014) Roy A Borchardt WORLD JOURNAL OF GASTROENTEROLOGY
- Immunologic consequences of chemotherapy for ovarian cancer: Impaired responses to the influenza vaccine
- (2013) Christina S. Chu et al. VACCINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started